DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
This Quarter Return
+8.8%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$285M
AUM Growth
+$285M
(+14%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
67.96%
Holding
106
New
7
Increased
9
Reduced
23
Closed
14
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$2.39M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
$1.6M |
| 3 |
Lexicon Pharmaceuticals
LXRX
|
$785K |
| 4 |
ZimVie
ZIMV
|
$567K |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$514K |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$7.16M |
| 2 |
Viking Therapeutics
VKTX
|
$2.34M |
| 3 |
LK
Luckin Coffee Inc. American Depositary Shares
LK
|
$2.11M |
| 4 |
Invesco AAA CLO Floating Rate Note ETF
ICLO
|
$1.25M |
| 5 |
Evolus
EOLS
|
$828K |
Sector Composition
| 1 | Healthcare | 30.44% |
| 2 | Materials | 27.67% |
| 3 | Financials | 18.27% |
| 4 | Communication Services | 6.88% |
| 5 | Technology | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Calumet Specialty Products
CLMT
$1.41B
| $77.1M | 27.08% |
4,325,000
| – | – |
|
2
Apollo Global Management
APO
$77.9B
| $28.1M | 9.88% |
225,000
| – | – |
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $19.1M | 6.71% |
112,220
| – | – |
|
4
AllianceBernstein
AB
$4.38B
| $16.7M | 5.89% |
48,000
-1,000
| -2% | -$349K |
|
5
Panagram BBB-B CLO ETF
CLOZ
$846M
| $14.6M | 5.13% |
542,868
| – | – |
|
6
DocGo
DCGO
$153M
| $10.2M | 3.58% |
3,070,850
| – | – |
|
7
AbbVie
ABBV
$372B
| $9.95M | 3.5% |
5,037
| – | – |
|
8
Pfizer
PFE
$141B
| $6.5M | 2.28% |
224,537
-24,200
| -10% | -$700K |
|
9
Apple
AAPL
$3.45T
| $5.81M | 2.04% |
2,494
| – | – |
|
|
VRNA
10
Verona Pharma
VRNA
$9.16B
| $5.18M | 1.82% |
180,000
-23,000
| -11% | -$662K |
|
11
OmniAb
OABI
$230M
| $4.86M | 1.71% |
1,148,505
+30,000
| +3% | +$127K |
|
|
12
Invesco AAA CLO Floating Rate Note ETF
ICLO
$344M
| $4.84M | 1.7% |
188,887
-48,866
| -21% | -$1.25M |
|
13
Ardelyx
ARDX
$1.53B
| $4.71M | 1.65% |
682,867
-90,000
| -12% | -$620K |
|
14
JPMorgan Chase
JPM
$829B
| $4.43M | 1.56% |
20,985
| – | – |
|
|
AVDL
15
Avadel Pharmaceuticals
AVDL
$1.43B
| $4.35M | 1.53% |
332,000
-1,000
| -0.3% | -$13.1K |
|
|
16
Janus Henderson AAA CLO ETF
JAAA
$24.9B
| $4.32M | 1.52% |
84,829
+31,432
| +59% | +$1.6M |
|
17
Catalyst Pharmaceutical
CPRX
$2.52B
| $4.22M | 1.48% |
212,000
| – | – |
|
18
Travere Therapeutics
TVTX
$1.56B
| $3.61M | 1.27% |
258,231
-7,735
| -3% | -$108K |
|
|
INZY
19
DELISTED
Inozyme Pharma
INZY
| $2.95M | 1.04% |
564,549
| – | – |
|
|
20
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.9M | 1.02% |
382,000
+67,693
| +22% | +$514K |
|
21
Xeris Biopharma Holdings
XERS
$1.26B
| $2.85M | 1% |
1,000,000
+180,000
| +22% | +$513K |
|
22
GSK
GSK
$79.9B
| $2.66M | 0.93% |
65,000
| – | – |
|
23
Immunovant
IMVT
$2.56B
| $2.62M | 0.92% |
92,000
+500
| +0.5% | +$14.3K |
|
|
24
Viking Therapeutics
VKTX
$3.04B
| $2.47M | 0.87% |
39,036
-37,000
| -49% | -$2.34M |
|
25
CSX Corp
CSX
$60.6B
| $2.42M | 0.85% |
70,000
| – | – |
|